Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-10-052251)

Filing Details

Accession Number:: 0001181431-10-052251
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-10-27 17:43:35
Reporting Period:: 2010-10-27

Filing Date:: 2010-10-27
Accepted Time:: 2010-10-27 17:43:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1338042	Aegerion Pharmaceuticals Inc.	AEGR	Pharmaceutical Preparations (2834)	202960116

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1314575	D Marc Beer	C/O Aegerion Pharmaceuticals, Inc. Centerpointe Iv, 1140 Route 22 East Bridgewater NJ 08807	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-10-27	105,263	$9.50	105,263	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$1.54		2020-09-15	885,653	885,653	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2020-09-15	885,653	885,653	Direct

Footnotes

The shares of common stock underlying this stock option vest in equal monthly installments over a four year period beginning on August 19, 2010.
Shares acquired upon the closing of the Issuer's initial public offering at the initial public offering price of $9.50 per share.